Oligonucleotide Drugs for Transthyretin Amyloidosis
Copyright policy ) Adams, D; Hawkins, PN; Polydefkis, M;
Oligonucleotide Drugs for Transthyretin Amyloidosis
In this issue of the Journal, Adams et al.1 and Benson et al.2 report the results of two randomized, double-blind, controlled trials testing the therapeutic efficacy of two different chemically mod...
- Johns Hopkins University United States
- Johns Hopkins Medicine United States
- University College London United Kingdom
- Scripps Research Institute United States
- Hospital de Santo António Portugal
Amyloid Neuropathies, Familial, Oligonucleotides, Prealbumin, Humans, Amyloidosis
Amyloid Neuropathies, Familial, Oligonucleotides, Prealbumin, Humans, Amyloidosis
citations This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).53 popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.Top 10% influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).Top 10% impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.Top 1%
citations
Citations provided by BIP!
This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).
Citations provided by BIP!popularityPopularity provided by BIP!
This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.
Popularity provided by BIP! 53
Top 10%
Top 10%
Top 1%
Green
bronze
